Beijing BIOOCUS Biotech Ltd. is proud to introduce our latest product, targeted therapy for Gastrointestinal Stromal Tumor (GIST). Our innovative approach utilizes advanced molecular targeting technology to specifically treat GIST, a rare form of sarcoma originating in the gastrointestinal tract. This therapy is designed to selectively block the activity of mutated cellular proteins, providing a more effective and well-tolerated treatment option for GIST patients, At Beijing BIOOCUS Biotech Ltd., we are committed to improving patient outcomes and quality of life through cutting-edge medical advancements. We are excited to bring this new targeted therapy to the market and make a meaningful impact in the fight against GIST
Please feel free to give your inquiry in the form below We will reply you in 24 hours